1. Home
  2. OTTR vs MLTX Comparison

OTTR vs MLTX Comparison

Compare OTTR & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OTTR
  • MLTX
  • Stock Information
  • Founded
  • OTTR 1907
  • MLTX 2021
  • Country
  • OTTR United States
  • MLTX Switzerland
  • Employees
  • OTTR N/A
  • MLTX N/A
  • Industry
  • OTTR Electric Utilities: Central
  • MLTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OTTR Utilities
  • MLTX Health Care
  • Exchange
  • OTTR Nasdaq
  • MLTX Nasdaq
  • Market Cap
  • OTTR 3.1B
  • MLTX 3.4B
  • IPO Year
  • OTTR N/A
  • MLTX N/A
  • Fundamental
  • Price
  • OTTR $77.50
  • MLTX $46.06
  • Analyst Decision
  • OTTR
  • MLTX Strong Buy
  • Analyst Count
  • OTTR 0
  • MLTX 7
  • Target Price
  • OTTR N/A
  • MLTX $84.20
  • AVG Volume (30 Days)
  • OTTR 214.9K
  • MLTX 498.7K
  • Earning Date
  • OTTR 02-17-2025
  • MLTX 02-27-2025
  • Dividend Yield
  • OTTR 2.41%
  • MLTX N/A
  • EPS Growth
  • OTTR 9.18
  • MLTX N/A
  • EPS
  • OTTR 7.24
  • MLTX N/A
  • Revenue
  • OTTR $1,341,750,000.00
  • MLTX N/A
  • Revenue This Year
  • OTTR $1.47
  • MLTX N/A
  • Revenue Next Year
  • OTTR $0.51
  • MLTX N/A
  • P/E Ratio
  • OTTR $10.66
  • MLTX N/A
  • Revenue Growth
  • OTTR 0.41
  • MLTX N/A
  • 52 Week Low
  • OTTR $71.66
  • MLTX $37.55
  • 52 Week High
  • OTTR $100.84
  • MLTX $64.98
  • Technical
  • Relative Strength Index (RSI)
  • OTTR 52.05
  • MLTX 44.11
  • Support Level
  • OTTR $76.42
  • MLTX $44.02
  • Resistance Level
  • OTTR $80.55
  • MLTX $48.00
  • Average True Range (ATR)
  • OTTR 1.82
  • MLTX 2.93
  • MACD
  • OTTR 0.23
  • MLTX 0.03
  • Stochastic Oscillator
  • OTTR 65.69
  • MLTX 51.90

About OTTR Otter Tail Corporation

Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

Share on Social Networks: